Trials / Unknown
UnknownNCT05238168
Evaluation of Digital Follow up of Preterm Infants
ePIPARI - Digital Follow-up of Preterm Infants During First Two Years
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (estimated)
- Sponsor
- Turku University Hospital · Other Government
- Sex
- All
- Age
- 1 Month – 28 Months
- Healthy volunteers
- Not accepted
Summary
The aim is to study how a digital follow up tool can identify the preterm born children and their families who need further support or clinical interventions
Detailed description
This study runs a digital follow up parallel to clinical follow up, up to 2 years of corrected age of the child. It evaluates the ability of the digital follow up tool to identify the problems in growth and health, eating and feeding, neurodevelopment and parental wellbeing which require further support or interventions. This study includes all infants born under 34 weeks of gestation in Turku University Hospital during years 2019-2022 and those preterm children born under 32 weeks of gestation who turn to 2 years during years 2019-2021. Parent satisfaction about the digital follow up tool is asked at each time point and anonymously once per year. The follow up age points are the expected day of birth, 1 month, 2 months, 4 months, 8 months, 12 months, 18 months and 24 months after the expected birth date.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | ePIPARI digital follow up tool | A digital platform includes questions to parents about child wellbeing and development and parent wellbeing. A notification by email or app comes two weeks before the follow up time point. The parents respond via a link to a webpage or via an app.They also receive information (text and video) about age-appropriate child development. ePIPARI includes 8 assessment points from term age until 2 years of corrected age. |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2025-04-30
- Completion
- 2025-04-30
- First posted
- 2022-02-14
- Last updated
- 2022-04-19
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT05238168. Inclusion in this directory is not an endorsement.